Metabolomics-assisted evaluation of differences and clinical value between ablation and surgical treatment for lung adenocarcinoma - Quiz - MDSpire

Metabolomics-assisted evaluation of differences and clinical value between ablation and surgical treatment for lung adenocarcinoma

  • By

  • Youli Wen

  • Yang Zeng

  • Wenqiang Li

  • Xinyu Deng

  • Wu Qunhua

  • Zhiping Deng

  • July 16, 2026

Share

Original Source(s)

Metabolomics-assisted evaluation of differences and clinical value between ablation and surgical treatment for lung adenocarcinoma

  • by Youli Wen, Yang Zeng, Wenqiang Li, Xinyu Deng, Wu Qunhua, Zhiping Deng

  • July 16, 2026

Related Content

Cost-Effectiveness of Universal Low-Dose Computed Tomographic Lung Cancer Screening in Singapore

First-line penpulimab combined with anlotinib achieves complete response in an elderly patient with occult lung squamous cell carcinoma: a case report

Diagnostic performance of a single breath-hold lung MRI scan with AI-powered compressed sensing for nodule detection in comparison to photon counting detector-CT